Chiome Bioscience (TSE:4583) EV-to-Revenue : 8.39 (As of May. 27, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Chiome Bioscience EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Chiome Bioscience's enterprise value is 円5,394.3 Mil. Chiome Bioscience's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was 円642.7 Mil. Therefore, Chiome Bioscience's EV-to-Revenue for today is 8.39.

The historical rank and industry rank for Chiome Bioscience's EV-to-Revenue or its related term are showing as below:

TSE:4583' s EV-to-Revenue Range Over the Past 10 Years
Min: 6.53 Med: 17.3 Max: 161.42
Current: 8.39

During the past 13 years, the highest EV-to-Revenue of Chiome Bioscience was 161.42. The lowest was 6.53. And the median was 17.30.

TSE:4583's EV-to-Revenue is ranked worse than
50.77% of 1038 companies
in the Biotechnology industry
Industry Median: 8.145 vs TSE:4583: 8.39

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Chiome Bioscience's stock price is 円114.00. Chiome Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was 円12.57. Therefore, Chiome Bioscience's PS Ratio for today is 9.07.

Chiome Bioscience EV-to-Revenue Historical Data

The historical data trend for Chiome Bioscience's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chiome Bioscience EV-to-Revenue Chart

Chiome Bioscience Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

10.32

10.07

8.90

11.22

8.90

Chiome Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															11.24	11.69	9.10	8.90	10.82

Competitive Comparison of Chiome Bioscience's EV-to-Revenue

For the Biotechnology subindustry, Chiome Bioscience's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chiome Bioscience's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chiome Bioscience's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Chiome Bioscience's EV-to-Revenue falls into.

Chiome Bioscience EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Chiome Bioscience's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	5394.292	/	642.704
	=	8.39

Chiome Bioscience's current Enterprise Value is 円5,394.3 Mil.
Chiome Bioscience's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円642.7 Mil.

Chiome Bioscience (TSE:4583) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Chiome Bioscience's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	114.00	/	12.57
	=	9.07

Chiome Bioscience's share price for today is 円114.00.
Chiome Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円12.57.

Chiome Bioscience EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Chiome Bioscience's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Chiome Bioscience (TSE:4583) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chiome Bioscience Inc (TSE:4583) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sumitomo Fudosan Nishi-shinjuku Building No.6, 3-12-1, Honmachi, Shibuya-ku, Tokyo, JPN, 151-0071

Website

http://www.chiome.co.jp

Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.

Chiome Bioscience (TSE:4583) Headlines

No Headlines